H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 20.81 CNY -4.98% Market Closed
Market Cap: 17.5B CNY
Have any thoughts about
Huaxia Eye Hospital Group Co Ltd?
Write Note

Huaxia Eye Hospital Group Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huaxia Eye Hospital Group Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash from Investing Activities
ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Cash from Investing Activities
-ÂĄ2.9B
CAGR 3-Years
-5%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash from Investing Activities
-ÂĄ3.4B
CAGR 3-Years
-12%
CAGR 5-Years
-19%
CAGR 10-Years
-22%
Hengkang Medical Group Co Ltd
SZSE:002219
Cash from Investing Activities
-ÂĄ333.3m
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
2%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash from Investing Activities
-ÂĄ551.2m
CAGR 3-Years
31%
CAGR 5-Years
31%
CAGR 10-Years
-12%
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash from Investing Activities
-ÂĄ1B
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
17.5B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co., Ltd. engages in the provision of ophthalmology specialist medical services. The company is headquartered in Xiamen, Fujian and currently employs 6,653 full-time employees. The company went IPO on 2022-11-07. The firm's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The firm is also engaged in glasses and pharmacy retail business. The firm mainly conducts its business in the domestic market.

Intrinsic Value
37.43 CNY
Undervaluation 44%
Intrinsic Value
Price
H

See Also

What is Huaxia Eye Hospital Group Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
1.9B CNY

Based on the financial report for Dec 31, 2023, Huaxia Eye Hospital Group Co Ltd's Cash from Investing Activities amounts to 1.9B CNY.

Back to Top